Sentences with phrase «immunobiology research»

Funding Research reported in this news release was supported by the National Center for Advancing Translational Sciences (award number 1 - UG3 - NS -105703-01) and the National Institute of Diabetes and Digestive and Kidney Diseases (award number R56DK106202 - 01) of the National Institutes of Health: the Cedars - Sinai Board of Governors Regenerative Medicine Institute; the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; and the Drown Foundation.

Funding Research reported in this news release was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R56DK106202 - 01, the Cedars - Sinai Board of Governors Regenerative Medicine Institute, the Cedars - Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute and the Drown Foundation.

Not exact matches

Take Kellie Ann Jurado, a postdoctoral scientist in immunobiology at Yale University, who will use the funding for research on the effects of the Zika virus on the nervous system.

Trained as a psychobiologist, his research has contributed to advancements in the fields of developmental psychology, physiological psychology, and perception; he has also made important contributions in the fields of genetics, developmental biology, immunobiology, ethology, and molecular biology.

Caetano Reis e Sousa, head of the immunobiology lab at Cancer Research UK's London Research Institute, sounds says the work is «exciting» but cautions that it is at an early stage.

Department of Cell Biology and Section of Immunobiology, Ludwig Institute for Cancer Research, Yale University School of Medicine, 333 Cedar Street, Post Office Box 208002, New Haven, CT 06520 — 8002, USA.

The research team, led by Akiko Iwasaki, professor of immunobiology and Howard Hughes Medical Institute investigator, decided to investigate using mice models of herpes simplex virus - 1, the dominant cause of genital herpes in the United States.

Dr. Nguyen is a research assistant professor in the Department of Neurology and a research scientist in the Department of Immunobiology at the University of Arizona.

The research team includes Dr. Masanori Miyata and Dr. Ji - Yun Lee at Georgia State; Dr. Richard A. Flavell, chair of the Department of Immunobiology, investigator at the Howard Hughes Medical Institute and a member of the National Academy of Sciences at Yale University; Dr. Koichi S. Kobayashi, professor in the Department of Microbial Pathogenesis and Immunology at the Texas A&M Health Science Center; and Dr. Hirofumi Kai at Kumamoto University in Japan.

Dr Katherine Woods is a Postdoctoral Research Fellow working in the Cancer Immunobiology Laboratory.

Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute

He was a member of the immunobiology study section of the National Institutes of Health and of the Leukemia Research Foundation's advisory board.

He holds a degree in biology from the Albert - Ludwigs - University and a Ph.D. from the Max Planck Institute of Immunobiology, and has a strong record of innovative scientific contributions, including peer - reviewed publications, patents and research grants.

«In essence, OX40 activates the IL - 9 gene in T helper cells, leading to the overproduction of IL - 9 through a powerful molecular machinery of super-enhancers that regulate gene expression,» says Dr. Xian C. Li, the director of the Immunobiology & Transplant Science Center at Houston Methodist Research Institute.

A discovery by Dr. Xian C. Li, the director of the Immunobiology & Transplant Science Center at Houston Methodist Research Institute, and his colleagues could lead to better drugs to treat asthma (Credit: Houston Methodist Research Institute)

We thank D.L. Court (National Cancer Institute) for plasmid pSIM18 for the generation of BAC - transgenic mice; J.G. Cyster (UC San Francisco) for Hy10 mice; E. Hobeika and M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for Mb1 - Cre mice; M. Nussenzweig (The Rockefeller University) for B1 - 8hi mice, anti-DEC205 — OVA and anti-DEC205 — CS; G.D. Victora (Whitehead Institute for Biomedical Research) for gene sets for the gene - set - enrichment analysis; O. Ohara, T. Watanabe and Y. Mochizuki for transcriptome analysis; W. Ise for discussions; M. Tochigi, C. Kawai, A. Arakawa and H. Masuda for technical assistance; P. Burrows for critical reading; and R. Brink for communicating unpublished results.

United Technologies Corporation professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University

The Chairman of the Scientific Council is Professor Thomas Boehm, Managing Director at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, the Chair of the Board of Trustees is Professor Dr. Jochen Maas, Head of Research and Development and Member of the Management Board, Sanofi - Aventis Deutschland GmbH.

This research will have a significant impact on understanding neoantigen - T cell immunobiology and could improve the treatment prospects of pancreatic cancer patients.

Dr. Lieping Chen currently serves as the United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology and Medical Oncology at Yale School of Medicine and co-Director of the Cancer Immunology Program of Yale Cancer Center in New Haven, CT..

James Allison, professor of immunology and chair of the Department of Immunology, The University of Texas MD Anderson Cancer Center Lieping Chen, United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University Gordon Freeman, professor of medicine, Dana - Farber Cancer Institute, Harvard Medical School Tasuku Honjo, professor of immunology and genomic medicine, Kyoto University Arlene Sharpe, the George Fabyan Professor of Comparative Pathology, Harvard Medical School; senior scientist, department of pathology, Brigham and Women's Hospital

Funding: This work was supported by the Alliance for Cancer Gene Therapy (R.H.V.), the Onyx and Breezy Foundation (K.U.S.), the Barry and Savannah Poodle Memorial Fund and the Mari Lowe Comparative Oncology Center (N.J.M.), the Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania (NIH grant P30 CA016520, R.H.V.), and the Oncology Research fund at the Veterinary Hospital of the University of Pennsylvania (K.U.S.).